✦ LIBER ✦

Novel anticancer agents in early clinical development

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

rViscumin, a novel anticancer agent — pr

✍ K. Wilhelm-Ogunbiyi; B. Möckel; A. Burger; M. Langer; H. Zinke; H.H. Fiebig; H. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Application of population pharmacokineti

✍ Ron J. Keizer; Miren K. Zamacona; Mendel Jansen; David Critchley; Jantien Wander 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 786 KB

CLINICAL DEVELOPMENT OF HISTONE DEACETYL

✍ Drummond, Daryl C.; Noble, Charles O.; Kirpotin, Dmitri B.; Guo, Zexiong; Scott, 📂 Article 📅 2005 🏛 Annual Reviews 🌐 English ⚖ 517 KB

Current challenges for the early clinica

✍ Christophe Le Tourneau; Véronique Diéras; Patricia Tresca; Wulfran Cacheux; Xavi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

PEG conjugates in clinical development o

✍ Gianfranco Pasut; Francesco M. Veronese 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 426 KB

Introduction: Role of Modeling and Simul

✍ Alex Sparreboom; Mats O. Karlsson 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 36 KB